Advances in neovascularization after diabetic ischemia

doi:10.4239/wjd.v13.i11.926

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6253)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

306

WORD

HTML

3087

Figures (1-4)

457

Tables (1-2)

271

Sum=4167

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

215

Download

745

Sum=960

Publishing Process of This Article

Item

Count

Browse

363

Download

763

Sum=1126

Nov 15, 2022 (publication date) through Mar 6, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Nov 15, 2022; 13(11): 926-939
Published online Nov 15, 2022. doi: 10.4239/wjd.v13.i11.926

Full Size Figure Download Figure

Figure 4 Cutting-edge approaches to therapeutic angiogenesis. ACEI: Angiotensin converting enzyme inhibitors; EPCs: Endothelial progenitor cells; VEGF: Vascular endothelial growth factor.

Citation: Cai Y, Zang GY, Huang Y, Sun Z, Zhang LL, Qian YJ, Yuan W, Wang ZQ. Advances in neovascularization after diabetic ischemia. World J Diabetes 2022; 13(11): 926-939
URL: https://www.wjgnet.com/1948-9358/full/v13/i11/926.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i11.926